Abstract
This prospective pilot study aims to evaluate the capabilities of novel quantitative ultrasound (QUS) methods based on attenuation (Att.PLUS) and sound speed (SSp.PLUS) for detecting liver fat. The study included 56 individuals with biopsy-proven steatosis (percutaneous liver biopsy) ranging from 0% to 90% of hepatocytes containing intracellular lipid vacuoles. Histopathology was considered reference standard. Abdominal QUS examinations were conducted using Att.PLUS and SSp.PLUS techniques on the Aixplorer MACH 30 system. Comparative assessments were made using the results of liver biopsy and magnetic resonance spectroscopy (MRS) together with magnetic resonance imaging proton density fat fraction (MRI-PDFF). MR examinations were performed on the Siemens VIDA 3T system. ROC analysis was conducted for two groups: (a) patients without steatosis (S0) versus those with steatosis (S1+S2+S3) yielded AUC values of 0.79 for Att.PLUS and 0.78 for SSp.PLUS, in contrast to an AUC>0.95 for MRS and MRI-PDFF; and (b) patients without or with mild steatosis (S0+S1) versus those with severe steatosis (S2+S3), yielded AUC values of 0.93 for Att.PLUS and 0.89 for SSp.PLUS, in contrast to an AUC>0.99 for MRS and MRI-PDFF. However, MR methods were superior in detecting liver fat content in obese patients and post-liver transplantation individuals. Both QUS parameters (Att.PLUS and SSp.PLUS) appear equivalent at differentiating S0 vs. (S1+S2+S3) patients, but the Att.PLUS parameter may be more effective at identifying advanced steatosis (S2+S3). MR techniques outperformed QUS methods, making them more suitable for clinical studies.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call